Targeting macrophages to reprogram the tumor immune microenvironment-Reference-Cited by-同舟云学术

Targeting macrophages to reprogram the tumor immune microenvironment

Published:2024-08-15 Issue:4 Volume:6 Page:e00203
ISSN:2543-6368
Container-title:Blood Science
language:en
Short-container-title:

Author:

Xie Zhidong¹,Liao Jing²,Chen Jun¹³⁴⁵

Affiliation:

1. Department of Immunology and Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China

2. GMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macau Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, Guangzhou, China

3. Guangdong Engineering and Technology Research Center for Disease-Model Animals, Laboratory Animal Center, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China

4. Key Laboratory of Tropical Disease Control of the Ministry of Education, Sun Yat-sen University, Guangzhou, China

5. Jinfeng Laboratory, Chongqing, China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference17 articles.

1. Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade.;Pang;Drug Resist Updat,2023

2. Multiomics prediction of response rates to therapies to inhibit programmed cell death 1 and programmed cell death 1 ligand 1.;Lee;JAMA Oncol,2019

3. Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells.;De Henau;Nature,2016

4. Sirpα on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47.;Huang;Nat Cancer,2024

5. Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response.;Mei;Nat Cancer,2023